Stay updated on KRAS G12C Inhibitor Clinical Trial
Sign up to get notified when there's something new on the KRAS G12C Inhibitor Clinical Trial page.

Latest updates to the KRAS G12C Inhibitor Clinical Trial page
- Check5 days agoChange DetectedNew entry Revision: v3.3.4 appears in the history and Revision: v3.3.3 is removed, a minor metadata update in the revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedThe history shows a new entry Revision: v3.3.2 and the previous Revision: v3.2.0 entry has been removed.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Contacts/Locations, Study Status, and Study Identification sections in the latest version (version 45, dated 2025-11-07); the previous government funding notice was removed.SummaryDifference0.8%

- Check76 days agoChange DetectedThe new screenshot shows additional entries in the Record History, reflecting routine administrative updates to the study record. There are no changes to the study design, eligibility criteria, outcomes, or other substantive content.SummaryDifference0.1%

- Check105 days agoChange DetectedAdded a government funding/status notice and updated version to v3.2.0; removed old v3.1.0 tag.SummaryDifference10%

Stay in the know with updates to KRAS G12C Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KRAS G12C Inhibitor Clinical Trial page.